Clinical Trials Directory

Trials / Unknown

UnknownNCT01664507

The Effect and Safety of Low Dose Nebulized Epinephrine in Croup

The Effect and Safety of Low Dose Nebulized Epinephrine in the Treatment of Croup

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
84 (estimated)
Sponsor
Seoul National University Hospital · Academic / Other
Sex
All
Age
6 Months – 5 Years
Healthy volunteers
Accepted

Summary

Croup is common illness presenting emergency department with dyspnea. The main treatment for croup is nebulized L-epinephrine and steroid. The study for the dose of nebulized L-epinephrine is restricted that the study of comparision between racemic epinephrine and L-epinephrine. The investigators conducted this study to compare the effectiveness of low dose L-epinephrine with conventional dose L-epinephrine.

Conditions

Interventions

TypeNameDescription
DRUGconventional dose epinephrineconventional dose epinephrine : 0.5mg/kg + 0.9% normal saline
DRUGlow dose epinephrinelow dose epineprhine : 0.1mg/kg + 0.9% normal saline

Timeline

Start date
2016-01-01
Primary completion
2018-08-01
Completion
2018-08-01
First posted
2012-08-14
Last updated
2018-01-09

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01664507. Inclusion in this directory is not an endorsement.